<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Syndromes with craniofacial abnormalities
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Syndromes with craniofacial abnormalities
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Syndromes with craniofacial abnormalities
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Edward P Buchanan, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Helen V Firth, DM, FRCP, FMedSci
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth TePas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Nov 30, 2022.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Interruption of normal embryologic growth and differentiation of the face and skull results in a wide variety of craniofacial abnormalities [
         <a href="#rid1">
          1
         </a>
         ]. Craniofacial surgery, which consists of reconstruction of the cranial vault and/or facial skeleton with or without simultaneous soft tissue reconstruction, can be performed when these deformities interfere with physical and/or mental well-being.
        </p>
        <p>
         Specific syndromes in which craniofacial abnormalities are the primary feature will be reviewed here. The pathogenesis, diagnosis, and surgical management of craniosynostosis (a subset of craniofacial anomalies) and syndromes in which craniosynostosis is a primary abnormality, are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/2910.html" rel="external">
          "Overview of craniosynostosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2942.html" rel="external">
          "Craniosynostosis syndromes"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CRANIOFACIAL MICROSOMIA
         </span>
         <span class="headingEndMark">
          —
         </span>
         Craniofacial microsomia (CFM), also referred to as hemifacial microsomia, oculo-auriculo-vertebral spectrum, or first and second branchial arch syndrome, is a sporadically acquired association of anomalies that results from a defect in development of the first and second branchial arches  (
         <a class="graphic graphic_figure graphicRef76109" href="/z/d/graphic/76109.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef69339" href="/z/d/graphic/69339.html" rel="external">
          figure 2
         </a>
         ) [
         <a href="#rid2">
          2-4
         </a>
         ]. It is sometimes associated with vertebral and/or ocular anomalies. Goldenhar syndrome appears to be part of this spectrum (MIM #164210) [
         <a href="#rid5">
          5,6
         </a>
         ]. The disorder occurs in approximately 1 in 5500 live births [
         <a href="#rid7">
          7
         </a>
         ]. It is typically sporadic [
         <a href="#rid8">
          8
         </a>
         ], but autosomal-dominant inheritance has been reported [
         <a href="#rid9">
          9,10
         </a>
         ].
        </p>
        <p>
         The mechanism underlying CFM is uncertain. A vascular insult to the developing branchial arches is the most widely accepted explanation. In an animal model, hemorrhage induced in the region of the first and second branchial arches produced the characteristic facial features. The degree of abnormality was proportional to the size of the hematoma [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Clinical features of CFM
         </span>
         <span class="headingEndMark">
          —
         </span>
         The stigmata of this disorder are indicated by the acronym OMENS, for
         <strong>
          o
         </strong>
         rbit,
         <strong>
          m
         </strong>
         andible,
         <strong>
          e
         </strong>
         ar, facial
         <strong>
          n
         </strong>
         erve,
         <strong>
          s
         </strong>
         oft tissue, although extracranial features also occur [
         <a href="#rid12">
          12,13
         </a>
         ]. Orbital distortion is typically present, as is mandibular hypoplasia. Ear anomalies include microtia, accessory preauricular tags and/or pits, and middle ear defects with hearing impairment  (
         <a class="graphic graphic_picture graphicRef57724" href="/z/d/graphic/57724.html" rel="external">
          picture 1
         </a>
         ) [
         <a href="#rid3">
          3
         </a>
         ]. Facial nerve involvement leads to hypoplasia of the facial muscles. Soft tissue deficiency, such as profound hypoplasia or absence of the parotid gland and masticatory muscles (temporalis, masseter), may be present.
        </p>
        <p>
         The defects are unilateral in 85 to 90 percent of cases. In these cases, the right side predominates [
         <a href="#rid3">
          3
         </a>
         ]. The abnormalities occur in variable combinations and range in extent from imperceptible to severe.
        </p>
        <p>
         The mandibular abnormalities are described using the Pruzansky classification  (
         <a class="graphic graphic_figure graphicRef81249" href="/z/d/graphic/81249.html" rel="external">
          figure 3
         </a>
         and
         <a class="graphic graphic_figure graphicRef71316" href="/z/d/graphic/71316.html" rel="external">
          figure 4
         </a>
         ) [
         <a href="#rid14">
          14
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type 1 is characterized by mild hypoplasia of the ramus with little abnormality of the mandibular body.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In type 2, the mandible has a small condylar head and ramus. The condyle is flat, the glenoid fossa is poorly developed or absent, and the infratemporal surface assumes a flat contour.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In type 3, the temporomandibular joint (TMJ) fails to form, and the ramus may exist as a thin bony lamina or may be completely absent. The increasing degree of mandibular hypoplasia is associated with increased difficulty with endotracheal intubation for anesthesia and surgery [
         <a href="#rid15">
          15
         </a>
         ].
        </p>
        <p>
        </p>
        <p>
         Bony abnormalities include a decreased maxillary height on the affected side and an occlusal cant, which is defined as rotation of the occlusal plane (a plane passing through the biting surface of the teeth) in the sagittal view [
         <a href="#rid16">
          16
         </a>
         ]. As a general guide, each degree of rotation of the occlusal plane results in a 0.5 mm change in the dental occlusal relationship. This rotation occurs in all types of CFM, with increasing severity from type 1 to type 3. Occlusal cant can be demonstrated clinically by having the child bite down on a tongue depressor to identify any angulation  (
         <a class="graphic graphic_figure graphicRef80119" href="/z/d/graphic/80119.html" rel="external">
          figure 5
         </a>
         ).
        </p>
        <p>
         The zygomatic arch is frequently hypoplastic, and the distance between the lateral orbit and the tragus of the ear is decreased. Cleft palate occurs in 25 percent of cases [
         <a href="#rid17">
          17
         </a>
         ].
        </p>
        <p>
         Auricular abnormalities are described using the OMENS+ classification [
         <a href="#rid18">
          18
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Grade 1 describes an external ear that is small but contains all of its components. The auditory canal is not affected.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A grade 2 abnormality is characterized by a vertical auricular remnant and complete atresia of the external auditory canal.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The most severe deformity is grade 3, in which there is a limited remnant of the ear lobe. Hearing does not correlate with the extent of external ear abnormality.
        </p>
        <p>
        </p>
        <p>
         One study reviewed the clinical features of 121 patients with CFM [
         <a href="#rid17">
          17
         </a>
         ]. Extracraniofacial anomalies occurred in 55 percent and ranged from one anomaly (13 percent) to multiple affected organ systems (42 percent). No gender or side predominance was detected. Central nervous system, cardiac, and skeletal anomalies each occurred in more than 10 percent of cases. Pulmonary, gastrointestinal, and renal deformities were less common. The majority of the heart defects involved the outflow tract or septum. The increased frequency of cardiac anomalies in this condition suggests that abnormal development of neural crest may result in both CFM and conotruncal defects.
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Surgery for CFM
         </span>
         <span class="headingEndMark">
          —
         </span>
         The majority of patients with CFM do not require surgical correction. This is usually reserved for severe cases. Surgical correction of CFM is usually performed in stages [
         <a href="#rid19">
          19
         </a>
         ]. Preauricular skin tags are typically excised before the child is two years old. This is often comforting to the parents, who see steps being taken to remedy their child's problem. Cranial remodeling may be required at approximately 8 to 12 months of age if the craniofacial abnormality is severe and orbital dystopia (malalignment of the orbits) is present. Surgical reconstruction of the oral commissure is performed before two years of age in patients with CFM.
        </p>
        <p>
         Distraction osteogenesis of the mandible can be used to correct severe mandibular hypoplasia with airway compromise [
         <a href="#rid20">
          20,21
         </a>
         ]. Children with a Pruzansky type 1 mandibular deformity are followed clinically from two to six years of age. Type 2 abnormalities respond favorably to distraction osteogenesis [
         <a href="#rid22">
          22
         </a>
         ]. The more severe type 3 deformities require reconstruction with a costochondral rib graft. There is still significant debate regarding the optimal timing to perform distraction osteogenesis. It has been postulated that by normalizing dimensions at a younger age, the maxilla and overlying soft tissue may have a longer time to develop with a balanced "functional matrix," thereby improving long-term facial symmetry [
         <a href="#rid21">
          21
         </a>
         ]. However, this hypothesis has yet to be confirmed by prospective outcome studies.
        </p>
        <p>
         The data on recurrence of the facial deformity after surgery over time are inconsistent as well. One study, for example, found that facial asymmetry improved significantly after distraction (surgical separation) [
         <a href="#rid23">
          23
         </a>
         ]. Despite mild relapse observed during the first year, surgical correction was stable in the later years of follow-up. However, another study found that the facial proportions gradually returned to their original asymmetry after the growth of the patient in those treated with mandibular distraction osteogenesis in early childhood, and this growth was similar to the outcomes in an untreated group of patients [
         <a href="#rid24">
          24
         </a>
         ]. While early surgery may have aesthetic and psychologic advantages, some of these patients may require a second procedure once their growth has completed.
        </p>
        <p>
         Orthodontic treatment is started at anywhere from 6 to 14 years of age [
         <a href="#rid25">
          25
         </a>
         ], and ear reconstruction is performed at approximately eight years. Ears can be fashioned from rib cartilage and placed under the mastoid skin. Alternatively, an osseointegrated post can be surgically implanted in the mastoid area, allowing a prosthetic ear to be firmly attached. The ear is displaced in a downward and anterior direction to accommodate future growth, and calvarial bone grafts may be needed to reconstruct the appropriate topography [
         <a href="#rid26">
          26
         </a>
         ].
        </p>
        <p>
         Craniofacial growth is completed at approximately 14 to 15 years of age [
         <a href="#rid27">
          27
         </a>
         ]. Further surgical intervention is initiated at that time. Maxillary repositioning (Le Fort 1), mandibular advancement [
         <a href="#rid28">
          28
         </a>
         ], and soft tissue augmentation in the form of microsurgical flap transfers and fat grafting are used to improve both form and function [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          TREACHER COLLINS SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Treacher Collins syndrome (TCS), also called mandibulofacial dysostosis, is an autosomal-dominant disorder of craniofacial development with a variable degree of penetrance. It occurs with a frequency of 1 in 25,000 to 1 in 50,000 live births [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Genetics and pathogenesis
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the majority of cases, abnormal bilateral first and second branchial arch development is due to mutations in the gene
         <em>
          TCOF1
         </em>
         (Treacher Collins-Franceschetti syndrome 1 [TCS1], MIM #154500), located on chromosome 5 (5q31.3-q33.3) [
         <a href="#rid31">
          31-35
         </a>
         ]. This gene encodes the protein treacle that plays an essential role in ribosomal ribonucleic acid (rRNA) transcription [
         <a href="#rid36">
          36
         </a>
         ] and ribosome biogenesis [
         <a href="#rid37">
          37
         </a>
         ] and shows peak expression in the neural crest cells of the branchial arches [
         <a href="#rid33">
          33,38
         </a>
         ]. Missense mutations in the
         <em>
          POLR1D
         </em>
         (polymerase I, RNA, subunit D) gene located at 13q12.2 cause TCS2 (MIM #613717). TCS type 1 and 2 are autosomal dominant. A third type, TCS3 is autosomal recessive and caused by compound heterozygous mutations in the
         <em>
          POLR1C
         </em>
         (polymerase I, RNA, subunit C) gene located at 6p22.3 (MIM #248390), which encode subunits of RNA polymerases I and III and have been detected in individuals with TCS who are negative for
         <em>
          TCOF1
         </em>
         mutations [
         <a href="#rid39">
          39
         </a>
         ]. The underlying genetic defect is still unknown in approximately 10 percent of patients with TCS.
        </p>
        <p>
         Macroscopically, craniofacial tissues such as cartilage, bone, and connective tissues fail to develop correctly as a direct result of neural crest cell dysfunction [
         <a href="#rid40">
          40
         </a>
         ]. One hypothesis posits that significant craniofacial malformations largely arise through defects in the formation, migration, or differentiation of this particular cell population [
         <a href="#rid41">
          41
         </a>
         ].
        </p>
        <p>
         According to Tessier's classification of clefts, this syndrome consists of a cleft between the 6 through 8 positions [
         <a href="#rid42">
          42
         </a>
         ]. TCS may result from insufficient mesodermal penetration affecting soft tissue thickness and leading to aplasia or hypoplasia of maxilla and zygoma. (See
         <a class="medical medical_review" href="/z/d/html/2920.html" rel="external">
          "Overview of craniofacial clefts and holoprosencephaly", section on 'Classification of clefts'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Clinical features of TCS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Affected patients have malar hypoplasia and a cleft in the zygoma [
         <a href="#rid30">
          30,43
         </a>
         ]. The eyes have an antimongoloid slant with colobomas (eyelid notch) along the lateral one-third of the lower lid. Lashes are absent from the medial two-thirds of the lower eyelid. The face has a convex profile with a retrusive chin and jaw, which is associated with a class 2 malocclusion (overbite).
        </p>
        <p>
         External ear abnormalities are common. Profound conductive hearing loss is common in severe cases, and children must be fitted early with bone-conducting hearing aids to facilitate development of normal speech. Cleft lip and palate and choanal atresia may occur. (See
         <a class="medical medical_review" href="/z/d/html/6298.html" rel="external">
          "Hearing loss in children: Treatment", section on 'Bone conduction hearing devices'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6769.html" rel="external">
          "Etiology, prenatal diagnosis, obstetric management, and recurrence of cleft lip and/or palate"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6301.html" rel="external">
          "Congenital anomalies of the nose", section on 'Choanal atresia'
         </a>
         .)
        </p>
        <p>
         The craniofacial abnormalities can result in airway narrowing and respiratory compromise. As a result, affected patients may require prone positioning or surgery to maintain a patent airway. Weak, uncoordinated swallowing may necessitate gavage feedings or placement of a gastrostomy tube. (See
         <a class="local">
          'Surgery for TCS'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h2">
          Surgery for TCS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with airway and feeding difficulties may require surgery during the first couple of years of life [
         <a href="#rid44">
          44-46
         </a>
         ]. These procedures may include tongue-lip adhesion (glossopexy), distraction osteogenesis of the mandible, tracheostomy, correction of cleft lip and/or palate and choanal atresia, and gastrostomy tube placement.
        </p>
        <p>
         Surgical correction of the facial abnormalities in patients with severe TCS is initiated at approximately seven years of age when a significant degree of facial growth has occurred. The zygomatic contour is improved using split calvarial bone grafts or iliac crest grafts [
         <a href="#rid45">
          45,47-49
         </a>
         ]. Lower eyelid colobomas are treated with a layered approach to reconstruction, using mucosal grafts to replace missing lining in conjunction with a lateral canthopexy.
        </p>
        <p>
         Surgical correction of the mandible is undertaken at 13 to 16 years of age as the jaw reaches dental and skeletal maturity. In the presence of a functioning temporomandibular joint (TMJ), the preferred treatment is ramus osteotomies and orthodontic manipulation. If the TMJ is absent, a costochondral graft is placed at 6 to 10 years of age and followed up with orthognathic surgery in adolescence. Bilateral distraction osteogenesis of the mandible is also used in an attempt to correct the mandibular hypoplasia [
         <a href="#rid44">
          44
         </a>
         ]. Finally, the contour of the facial soft tissues generally requires correction at a later stage when the patient has achieved facial skeletal maturity. The use of microsurgical free flap transfer has improved correction of facial soft tissue contours [
         <a href="#rid50">
          50
         </a>
         ].
        </p>
        <p>
         Improvement in facial appearance has positive psychosocial and social influences. In one report, 20 patients with TCS (mean age 12.2 years) were studied before and at intervals up to four years after craniofacial reconstruction [
         <a href="#rid51">
          51
         </a>
         ]. Although intellectual ability was unchanged, appearance, self-esteem, and adaptive function improved. The improvement peaked at the one year postoperative assessment and subsequently leveled off.
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          PIERRE ROBIN SEQUENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pierre Robin sequence, also known as Pierre Robin syndrome, is a condition with multiple causes [
         <a href="#rid52">
          52,53
         </a>
         ]. Most cases are thought to result from hypoplasia of the mandible that occurs before the ninth week of development. Prior to the eighth week, the tongue is interposed between the developing palatal shelves. In the normal course of development, the tongue is drawn down during the 10
         <sup>
          th
         </sup>
         and 11
         <sup>
          th
         </sup>
         weeks, allowing fusion of the palatal shelves. In the Pierre Robin sequence, hypoplasia of the mandible results in posterior displacement of the tongue, preventing palatal closure and producing a cleft palate. The etiology of Pierre Robin sequence is uncertain. Possible mechanisms include genetic disorders, oligohydramnios (which may limit chin growth), myotonia, or connective tissue disease.
        </p>
        <p>
         Pierre Robin sequence often is an isolated abnormality. However, some cases (37 percent in one series of 74 patients) occur as part of a syndrome with multiple malformations [
         <a href="#rid54">
          54
         </a>
         ]. One-third of the patients with associated malformations had Stickler syndrome or velocardiofacial syndrome (VCFS). Some cases of Pierre Robin sequence may thus result from developmental misexpression of SOX9 (sex-reversed Y chromosome [SRY]-box 9, a transcription factor essential for sex and skeletal development) due to disruption of very long range cis regulatory elements [
         <a href="#rid55">
          55
         </a>
         ]. Ophthalmologic examination and fluorescence in situ hybridization (FISH) study for chromosome 22 deletion should be performed on patients with Pierre Robin sequence because of the association with Stickler syndrome and VCFS. (See
         <a class="local">
          'Stickler and Marshall syndromes'
         </a>
         below and
         <a class="local">
          'Velocardiofacial (Shprintzen) syndrome'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Clinical features of Pierre Robin sequence
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical features of Pierre Robin sequence are micrognathia, glossoptosis, and cleft palate  (
         <a class="graphic graphic_picture graphicRef68928" href="/z/d/graphic/68928.html" rel="external">
          picture 2
         </a>
         ). The tongue tends to prolapse backward, leading to airway obstruction that can be life threatening. Respiratory compromise can lead to hypoxia, cardiopulmonary arrest, pulmonary hypertension, and failure to thrive. Feeding problems are common [
         <a href="#rid54">
          54
         </a>
         ].
        </p>
        <p>
         The rapid facial growth that occurs from 3 to 12 months of age leads to resolution of airway problems in a majority of cases. The mortality associated with Pierre Robin sequence is generally related to airway compromise and is higher when associated with prematurity. Mortality rates in term infants with Pierre Robin sequences range from 1.7 to 11.3 percent [
         <a href="#rid53">
          53,56
         </a>
         ]. However, the reported mortality rate increases to 26 percent when other anomalies are present [
         <a href="#rid53">
          53
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H11">
         <span class="h2">
          Management of Pierre Robin sequence
         </span>
         <span class="headingEndMark">
          —
         </span>
         The two primary issues in patients with Pierre Robin sequence are upper airway obstruction and feeding difficulties [
         <a href="#rid53">
          53,57
         </a>
         ]. Affected patients should be monitored to detect apnea and airway obstruction. Prone positioning is indicated, especially during feeding, to minimize airway obstruction. A rubber tube placed through the nose (nasopharyngeal trumpet) may protect the airway while awaiting compensatory growth. More invasive temporizing procedures are needed if respiratory obstruction is unresponsive to conservative measures.
        </p>
        <p>
         Nonsurgical options for treatment of upper airway obstruction include noninvasive respiratory support (NRS) and a nasopharyngeal airway (NPA). Surgical options include mandibular distraction osteogenesis and glossopexy. Cases of airway obstruction that are refractory to these measures may require a tracheostomy [
         <a href="#rid54">
          54
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/4389.html" rel="external">
          "Tracheostomy: Rationale, indications, and contraindications"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         NRS uses continuous positive airway pressure or noninvasive positive pressure ventilation to correct the airway obstruction. In a series of 81 patients over 10 years, 63 percent were treated with positioning and medical treatment, 12 percent required temporary intubation and positioning, 16 percent required tracheotomy, and 9 percent were treated with NRS [
         <a href="#rid58">
          58
         </a>
         ]. NRS was shown to improve breathing patterns, respiratory efforts, and transcutaneous carbon dioxide pressures in infants with severe upper airway obstruction due to Pierre Robin sequence. None of the seven infants treated with NRS required tracheostomy, and six out of seven were able to discontinue nutritional support.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A second nonsurgical option to relieve airway obstruction is placement of a NPA [
         <a href="#rid59">
          59-61
         </a>
         ]. Improved oxygen saturation and weight gain have been documented with this method.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Distraction of the mandible, in which osteotomy or fracture of the mandible is performed and an external fixator is used to open the oral passage, is the most commonly used surgical procedure [
         <a href="#rid62">
          62-64
         </a>
         ]. Distraction has the benefit of affecting permanent change in mandibular size creating adequate space for the tongue. It has allowed many patients to avoid tracheostomy.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Historically, glossopexy or tongue-lip adhesion, where the tongue is sutured to the lip to prevent retrusion, was the surgical method of choice. The use of glossopexy has decreased in popularity; however, it is associated with decreased morbidity and normalized weight gain and remains a valid alternative [
         <a href="#rid65">
          65,66
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H12">
         <span class="h1">
          NAGER SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nager syndrome, also known as Nager acrofacial dysostosis syndrome, is a rare disorder [
         <a href="#rid67">
          67,68
         </a>
         ]. Most cases are sporadic, although both autosomal-recessive and autosomal-dominant inheritance have been reported [
         <a href="#rid69">
          69
         </a>
         ]. Mutations in
         <em>
          SF3B4
         </em>
         (splicing factor 3B, subunit 4) leading to haploinsufficiency were identified in 61 percent of affected individuals in one cohort [
         <a href="#rid70">
          70
         </a>
         ].
         <em>
          SF3B4
         </em>
         encodes spliceosome-associated protein 49 kD (SAP49), a subunit of the pre-messenger ribonucleic acid (mRNA) spliceosome complex.
        </p>
        <p>
         The craniofacial features of Nager syndrome are similar to those of Treacher Collins syndrome (TCS). Nager syndrome is distinguished from TCS by the absence of eyelid colobomas. Severe cleft palate is always present. The palatal defect is unique in that the cleft is wide, but the hard and soft palates are shortened in the anterior-posterior dimension. Characteristic limb anomalies include preaxial deformities such as hypoplasia or agenesis of the radius and thumb [
         <a href="#rid71">
          71
         </a>
         ]. Affected children have short stature. Intelligence is normal, although delays in speech and language development may occur secondary to hearing impairment [
         <a href="#rid67">
          67,72
         </a>
         ].
        </p>
        <p>
         Infants with Nager syndrome frequently have respiratory and feeding problems that may require gavage feeding or gastrostomy tube placement. The high perinatal mortality rate (approximately 11 percent) is related to respiratory compromise [
         <a href="#rid73">
          73
         </a>
         ].
        </p>
        <p>
         Management is similar to that for the Pierre Robin sequence as described above [
         <a href="#rid74">
          74
         </a>
         ]. (See
         <a class="local">
          'Pierre Robin sequence'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h1">
          BINDER SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Binder syndrome, also known as maxillonasal dysplasia, is a very rare disorder of unknown etiology [
         <a href="#rid75">
          75
         </a>
         ]. It is hypothesized that Binder syndrome is the mildest form of chondrodysplasia punctata [
         <a href="#rid76">
          76
         </a>
         ]. Binder syndrome is characterized by a shortened nose with an acute nasolabial angle and a convex upper lip  (
         <a class="graphic graphic_picture graphicRef53807" href="/z/d/graphic/53807.html" rel="external">
          picture 3
         </a>
         ). Class III malocclusion may be present. An underdeveloped frontal sinus and cervicospinal abnormalities occur in 40 to 50 percent of cases [
         <a href="#rid77">
          77
         </a>
         ].
        </p>
        <p>
         The treatment consists of nasal and maxillary correction, followed by orthodontic rehabilitation [
         <a href="#rid78">
          78,79
         </a>
         ]. Depending on the involvement of the malformation, surgical treatment can be limited to reconstruction of the nasal dorsum and apex only or extend to include maxillary advancement. Grafting to the nasal osteochondral scaffold can be performed in early adolescence; however, osteotomy with maxillary advancement should be reserved until the late teenage years [
         <a href="#rid80">
          80
         </a>
         ]. Surgeons have reported the use of bone and cartilage grafts, and a comparison between the two demonstrated that either option is adequate for creating a normal nasolabial angle and tip projection [
         <a href="#rid81">
          81,82
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H15">
         <span class="h1">
          VELOCARDIOFACIAL (SHPRINTZEN) SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Velocardiofacial syndrome (VCFS), also known as Shprintzen syndrome, is an autosomal-dominant disorder caused by a deletion in chromosome 22q11 [
         <a href="#rid83">
          83,84
         </a>
         ]. This deletion has also been identified in the majority of patients with DiGeorge sequence and conotruncal anomaly face syndrome, suggesting that these are phenotypic variants of the same disorder [
         <a href="#rid84">
          84
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3905.html" rel="external">
          "DiGeorge (22q11.2 deletion) syndrome: Epidemiology and pathogenesis"
         </a>
         .)
        </p>
        <p>
         The deletion occurs in approximately 1 in 4000 live births [
         <a href="#rid84">
          84
         </a>
         ] and can be detected by fluorescence in situ hybridization (FISH), multiple ligation-dependent probe amplification (MLPA), and array comparative genomic hybridization (aCGH). The deletion occurs "de novo" in the majority of cases, but approximately 15 percent are inherited from an affected parent. (See
         <a class="medical medical_review" href="/z/d/html/2893.html" rel="external">
          "Tools for genetics and genomics: Cytogenetics and molecular genetics", section on 'Detecting cytogenetic abnormalities'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/16647.html" rel="external">
          "Genomic disorders: An overview", section on 'Detection of genomic disorders'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H16">
         <span class="h2">
          Clinical features of VCFS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Affected patients have retrognathia, a long face with a prominent nose [
         <a href="#rid85">
          85
         </a>
         ]. Velopharyngeal incompetence (weak pharyngeal musculature) producing speech abnormalities such as hypernasal speech is very common. Submucous or overt clefts of the secondary palate can occur. Chronic otitis media is present in 75 percent of cases. Transient neonatal hypocalcemia occurs in 20 percent. (See
         <a class="medical medical_review" href="/z/d/html/5060.html" rel="external">
          "Neonatal hypocalcemia"
         </a>
         .)
        </p>
        <p>
         Congenital heart defects occur in 85 percent of cases [
         <a href="#rid85">
          85
         </a>
         ]. The most common are ventricular septal defect (62 percent), right-sided aortic arch (52 percent), and tetralogy of Fallot (21 percent). The carotid arteries frequently follow an anomalous course that may complicate the performance of pharyngeal surgical procedures. (See
         <a class="medical medical_review" href="/z/d/html/5787.html" rel="external">
          "Isolated ventricular septal defects (VSDs) in infants and children: Anatomy, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5757.html" rel="external">
          "Vascular rings and slings"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5769.html" rel="external">
          "Tetralogy of Fallot (TOF): Pathophysiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5785.html" rel="external">
          "Diagnosis and initial management of cyanotic heart disease in the newborn"
         </a>
         .)
        </p>
        <p>
         Learning disabilities are frequent, and mild intellectual impairment occurs in approximately 40 percent of patients. (See
         <a class="medical medical_review" href="/z/d/html/610.html" rel="external">
          "Specific learning disorders in children: Clinical features", section on 'Risk factors'
         </a>
         .)
        </p>
        <p>
         Psychiatric disorders, primarily schizophrenia and paranoid delusions, develop in 10 to 30 percent of cases [
         <a href="#rid86">
          86,87
         </a>
         ]. Magnetic resonance imaging studies comparing patients with VCFS and controls have demonstrated structural changes in the temporal lobe, left hippocampal, frontal, and caudate areas that are similar to the alterations of these regions that are seen in patients with schizophrenia [
         <a href="#rid88">
          88,89
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H17">
         <span class="h2">
          Management of VCFS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Pharyngeal surgery (pharyngoplasty) is frequently required to treat the nasal air escape that causes abnormal speech [
         <a href="#rid90">
          90,91
         </a>
         ]. High inset of the pharyngeal flap is indicated because of severe, refractory velopharyngeal incompetence. This is technically difficult because of visualization issues. Some authors report success with through and through dissection of the soft palate to allow direct visualization of flap placement [
         <a href="#rid92">
          92
         </a>
         ].
        </p>
        <p>
         Removal of the tonsils and adenoids is contraindicated because they aid in velopharyngeal closure [
         <a href="#rid93">
          93
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          STICKLER AND MARSHALL SYNDROMES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Stickler (also known as hereditary arthroophthalmopathy) and Marshall syndromes are related disorders of connective tissue with overlapping characteristics [
         <a href="#rid94">
          94-96
         </a>
         ]. It is unclear whether they are distinct entities or different clinical manifestations of a single syndrome. Most patients have autosomal-dominant inheritance, although autosomal-recessive forms of Stickler syndrome occur.
        </p>
        <p>
         Mutations of the gene for the alpha-1 chain of type II collagen (
         <em>
          COL2A1
         </em>
         ), located on chromosome 12q13.11-q13.2, cause Stickler syndrome type I (MIM #108300) [
         <a href="#rid97">
          97
         </a>
         ]. These mutations result in the abnormal production and assembly of type II collagen, which is a major component of cartilage, vitreous, and nucleus pulposus. Mutations in the
         <em>
          COL11A1
         </em>
         gene, located at 1p21, that encodes the alpha-1 chain of type XI collagen have been found in patients with Stickler syndrome type II (MIM #604841) or Marshall syndrome (MIM #154780) or with overlapping phenotypes of both [
         <a href="#rid98">
          98
         </a>
         ]. Stickler syndrome type III (MIM #184840) is caused by mutation in the
         <em>
          COL11A2
         </em>
         gene, located at 6p21.3 [
         <a href="#rid99">
          99
         </a>
         ]. Rare autosomal-recessive forms of Stickler syndrome are caused by biallelic mutations in any of the three genes encoding collagen IX (ie,
         <em>
          COL9A1
         </em>
         ,
         <em>
          COL9A2
         </em>
         , and
         <em>
          COL9A3
         </em>
         ) [
         <a href="#rid100">
          100,101
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h2">
          Clinical features
         </span>
         <span class="headingEndMark">
          —
         </span>
         The clinical features of Stickler syndrome include characteristic orofacial and ophthalmologic abnormalities, deafness, and arthritis [
         <a href="#rid95">
          95,96,98
         </a>
         ]. Affected patients typically have a flat midface with a depressed nasal bridge, short nose, anteverted nares, and micrognathia. Cleft of the soft palate can occur and is associated with Pierre Robin sequence. Abnormal architecture of the vitreous gel is pathognomonic of this disorder and is usually associated with high myopia. Retinal detachment (also called ablatio retinae) occurs frequently and is considered a medical emergency [
         <a href="#rid102">
          102
         </a>
         ]. Joint hypermobility is present in infancy and decreases with age. Patients typically develop osteoarthritis in the third or fourth decade. Some patients have sensorineural deafness. Mitral valve prolapse may occur. (See
         <a class="local">
          'Pierre Robin sequence'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/6910.html" rel="external">
          "Retinal detachment"
         </a>
         .)
        </p>
        <p>
         Marshall syndrome has clinical features similar to Stickler syndrome. These include a craniofacial appearance characterized by a flat midface, depressed nasal bridge, short nose, and anteverted nares. Patients have ocular abnormalities (eg, cataracts, myopia), sensorineural hearing loss, and spondyloepiphyseal abnormalities [
         <a href="#rid103">
          103
         </a>
         ]. Hypohidrotic ectodermal dysplasia may occur [
         <a href="#rid104">
          104
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/6270.html" rel="external">
          "Cataract in children", section on 'Clinical features'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/110146.html" rel="external">
          "Ectodermal dysplasias"
         </a>
         .)
        </p>
        <p>
         Early ophthalmologic examination is indicated, and follow-up is essential given the difficulty in slit-lamp examination of infants and young children. Treatment of Pierre Robin sequence is discussed above (see
         <a class="local">
          'Management of Pierre Robin sequence'
         </a>
         above). Cleft palate, if present, should be repaired prior to speech production. Surgery is performed earlier in infancy if the airway is unstable. Further surgery for speech competence is often indicated because of the increased incidence of velopharyngeal insufficiency in these patients. Otolaryngologists should be consulted for auditory concerns. Orthopedic surgery and physical therapy are often involved in patient care for early onset of arthritis, which is most commonly treated with over-the-counter anti-inflammatories.
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h1">
          VAN DER WOUDE SYNDROME
         </span>
         <span class="headingEndMark">
          —
         </span>
         Van der Woude syndrome is an autosomal-dominant disorder with a high degree of penetration. It is characterized by pits and/or sinuses in the lower lip and cleft lip and/or cleft palate [
         <a href="#rid105">
          105
         </a>
         ]. This condition represents 1 percent of cleft lip and palate cases and should be suspected when lower lip pits are present  (
         <a class="graphic graphic_picture graphicRef50289" href="/z/d/graphic/50289.html" rel="external">
          picture 4
         </a>
         ). Identification of this syndrome is important for genetic counseling because of the 50 percent risk of occurrence in the offspring of an affected individual. The syndrome is usually caused by mutations in the
         <em>
          IRF6
         </em>
         (interferon regulatory factor 6) gene, located on chromosome 1q32-41, but another locus has been identified at 1p34 where the candidate gene
         <em>
          WDR65
         </em>
         (Tryptophan-Aspartic acid [W-D] dipeptide repeat-containing protein 65) resides [
         <a href="#rid105">
          105-108
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3029582582">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/120234.html" rel="external">
          "Society guideline links: Syndromes with craniofacial anomalies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H14783287">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Specific syndromes with craniofacial abnormalities
         </strong>
         – Interruption of normal embryologic growth and differentiation of the face and skull results in a wide variety of craniofacial abnormalities  (
         <a class="graphic graphic_figure graphicRef76109" href="/z/d/graphic/76109.html" rel="external">
          figure 1
         </a>
         and
         <a class="graphic graphic_figure graphicRef69339" href="/z/d/graphic/69339.html" rel="external">
          figure 2
         </a>
         ). There are several syndromes in which craniofacial abnormalities are the primary feature (see
         <a class="local">
          'Introduction'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Craniofacial microsomia
         </strong>
         – The defects in craniofacial microsomia involve the orbit, mandible, ear, facial nerve, and soft tissue and are typically unilateral  (
         <a class="graphic graphic_picture graphicRef57724" href="/z/d/graphic/57724.html" rel="external">
          picture 1
         </a>
         ). (See
         <a class="local">
          'Craniofacial microsomia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Treacher-Collins syndrome (TCS)
         </strong>
         – Patients with TCS have jaw defects, a notch in the lower eyelid at the junction of the inner two-thirds and outer one-third (eyelid colobomas), partially absent lashes on the lower eyelids, and sensorineural hearing loss. Cleft lip and palate and choanal atresia may occur. The craniofacial abnormalities can result in respiratory compromise and feeding difficulties. (See
         <a class="local">
          'Treacher Collins syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Pierre Robin sequence
         </strong>
         – Pierre Robin sequence, also known as Pierre Robin syndrome, is a condition with multiple causes. Most cases are thought to result from hypoplasia of the mandible that occurs before the ninth week of development  (
         <a class="graphic graphic_picture graphicRef68928" href="/z/d/graphic/68928.html" rel="external">
          picture 2
         </a>
         ). Some cases occur as part of a syndrome with multiple malformations (eg, Stickler syndrome or velocardiofacial syndrome [VCFS]). (See
         <a class="local">
          'Pierre Robin sequence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Nager syndrome
         </strong>
         – The craniofacial features of Nager syndrome are similar to those of TCS. Nager syndrome is distinguished from TCS by the absence of eyelid colobomas. Severe cleft palate is always present. (See
         <a class="local">
          'Nager syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Binder syndrome
         </strong>
         – Binder syndrome is characterized by a shortened nose with an acute nasolabial angle and a convex upper lip. (See
         <a class="local">
          'Binder syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Velocardiofacial syndrome (VCFS)
         </strong>
         – VCFS, also known as Shprintzen syndrome, is an autosomal-dominant disorder caused by a deletion in chromosome 22q11. This deletion has also been identified in the majority of patients with DiGeorge sequence and conotruncal anomaly face syndrome. Common clinical features include cleft palate, velopharyngeal incompetence (weak pharyngeal musculature) producing speech abnormalities, chronic otitis media, hypotonia, and congenital heart defects. (See
         <a class="local">
          'Velocardiofacial (Shprintzen) syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Stickler syndrome and Marshall syndrome
         </strong>
         – Stickler and Marshall syndromes have similar clinical features, including a craniofacial appearance characterized by a flat midface, depressed nasal bridge, short nose, and anteverted nares. Stickler syndrome is also characterized by abnormal architecture of the vitreous gel and osteoarthritis. However, there is limited information to distinguish the two syndromes aside from clinical manifestations. (See
         <a class="local">
          'Stickler and Marshall syndromes'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Van der Woude syndrome
         </strong>
         – Van der Woude syndrome is characterized by pits and/or sinuses in the lower lip and cleft lip and/or cleft palate  (
         <a class="graphic graphic_picture graphicRef50289" href="/z/d/graphic/50289.html" rel="external">
          picture 4
         </a>
         ). (See
         <a class="local">
          'Van der Woude syndrome'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Management
         </strong>
         – Patients with airway and feeding difficulties may require surgery during the first couple years of life. The most common surgical procedure used to correct mandibular hypoplasia is that distraction osteogenesis of the mandible. Other surgeries may be performed during early and later childhood for functional reasons, as well as for aesthetic and psychologic reasons. (See
         <a class="local">
          'Surgery for CFM'
         </a>
         above and
         <a class="local">
          'Surgery for TCS'
         </a>
         above and
         <a class="local">
          'Management of Pierre Robin sequence'
         </a>
         above and
         <a class="local">
          'Management of VCFS'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H736083576">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Patrick Cole, MD and Larry H Hollier, Jr, MD, who contributed to earlier versions of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Roth DM, Bayona F, Baddam P, Graf D. Craniofacial Development: Neural Crest in Molecular Embryology. Head Neck Pathol 2021; 15:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Converse JM, Coccaro PJ, Becker M, Wood-Smith D. On hemifacial microsomia. The first and second branchial arch syndrome. Plast Reconstr Surg 1973; 51:268.
          </a>
         </li>
         <li class="breakAll">
          Jones KL. Oculo-auriculo-vertebral spectrum (First and second branchial arch syndrome, facio-auriculo-vertebral spectrum, hemifacial microsomia, Goldenhar syndrome). In: Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006. p.738.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Strömland K, Miller M, Sjögreen L, et al. Oculo-auriculo-vertebral spectrum: associated anomalies, functional deficits and possible developmental risk factors. Am J Med Genet A 2007; 143A:1317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Skarzyński H, Porowski M, Podskarbi-Fayette R. Treatment of otological features of the oculoauriculovertebral dysplasia (Goldenhar syndrome). Int J Pediatr Otorhinolaryngol 2009; 73:915.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tuna EB, Orino D, Ogawa K, et al. Craniofacial and dental characteristics of Goldenhar syndrome: a report of two cases. J Oral Sci 2011; 53:121.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kelberman D, Tyson J, Chandler DC, et al. Hemifacial microsomia: progress in understanding the genetic basis of a complex malformation syndrome. Hum Genet 2001; 109:638.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ala-Mello S, Siggberg L, Knuutila S, et al. Further evidence for a relationship between the 5p15 chromosome region and the oculoauriculovertebral anomaly. Am J Med Genet A 2008; 146A:2490.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vendramini-Pittoli S, Kokitsu-Nakata NM. Oculoauriculovertebral spectrum: report of nine familial cases with evidence of autosomal dominant inheritance and review of the literature. Clin Dysmorphol 2009; 18:67.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tasse C, Majewski F, Böhringer S, et al. A family with autosomal dominant oculo-auriculo-vertebral spectrum. Clin Dysmorphol 2007; 16:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poswillo D. The pathogenesis of the first and second branchial arch syndrome. Oral Surg Oral Med Oral Pathol 1973; 35:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vento AR, LaBrie RA, Mulliken JB. The O.M.E.N.S. classification of hemifacial microsomia. Cleft Palate Craniofac J 1991; 28:68.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gougoutas AJ, Singh DJ, Low DW, Bartlett SP. Hemifacial microsomia: clinical features and pictographic representations of the OMENS classification system. Plast Reconstr Surg 2007; 120:112e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pruzansky S. Not all dwarfed mandibles are alike. Birth Defects 1969; 5:120.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nargozian C, Ririe DG, Bennun RD, Mulliken JB. Hemifacial microsomia: anatomical prediction of difficult intubation. Paediatr Anaesth 1999; 9:393.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Padwa BL, Kaiser MO, Kaban LB. Occlusal cant in the frontal plane as a reflection of facial asymmetry. J Oral Maxillofac Surg 1997; 55:811.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horgan JE, Padwa BL, LaBrie RA, Mulliken JB. OMENS-Plus: analysis of craniofacial and extracraniofacial anomalies in hemifacial microsomia. Cleft Palate Craniofac J 1995; 32:405.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Birgfeld CB, Luquetti DV, Gougoutas AJ, et al. A phenotypic assessment tool for craniofacial microsomia. Plast Reconstr Surg 2011; 127:313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Converse JM, Horowitz SL, Coccaro PJ, Wood-Smith D. The corrective treatment of the skeletal asymmetry in hemifacial microsomia. Plast Reconstr Surg 1973; 52:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy JG, Schreiber J, Karp N, et al. Lengthening the human mandible by gradual distraction. Plast Reconstr Surg 1992; 89:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hollier LH, Kim JH, Grayson B, McCarthy JG. Mandibular growth after distraction in patients under 48 months of age. Plast Reconstr Surg 1999; 103:1361.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gateño J, Teichgraeber JF, Aguilar E. Distraction osteogenesis: a new surgical technique for use with the multiplanar mandibular distractor. Plast Reconstr Surg 2000; 105:883.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shetye PR, Grayson BH, Mackool RJ, McCarthy JG. Long-term stability and growth following unilateral mandibular distraction in growing children with craniofacial microsomia. Plast Reconstr Surg 2006; 118:985.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meazzini MC, Mazzoleni F, Bozzetti A, Brusati R. Comparison of mandibular vertical growth in hemifacial microsomia patients treated with early distraction or not treated: follow up till the completion of growth. J Craniomaxillofac Surg 2012; 40:105.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Meazzini MC, Mazzoleni F, Bozzetti A, Brusati R. Does functional appliance treatment truly improve stability of mandibular vertical distraction osteogenesis in hemifacial microsomia? J Craniomaxillofac Surg 2008; 36:384.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yamada A, Ueda K, Yorozuya-Shibazaki R. External ear reconstruction in hemifacial microsomia. J Craniofac Surg 2009; 20 Suppl 2:1787.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stahl F, Baccetti T, Franchi L, McNamara JA Jr. Longitudinal growth changes in untreated subjects with Class II Division 1 malocclusion. Am J Orthod Dentofacial Orthop 2008; 134:125.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy JG. Craniofacial microsomia. A primary or secondary surgical treatment program. Clin Plast Surg 1997; 24:459.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Longaker MT, Siebert JW. Microvascular free-flap correction of severe hemifacial atrophy. Plast Reconstr Surg 1995; 96:800.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon J, Trainor P, Dixon MJ. Treacher Collins syndrome. Orthod Craniofac Res 2007; 10:88.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. The Treacher Collins Syndrome Collaborative Group. Nat Genet 1996; 12:130.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marsh KL, Dixon J, Dixon MJ. Mutations in the Treacher Collins syndrome gene lead to mislocalization of the nucleolar protein treacle. Hum Mol Genet 1998; 7:1795.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shows KH, Shiang R. Regulation of the mouse Treacher Collins syndrome homolog (Tcof1) promoter through differential repression of constitutive expression. DNA Cell Biol 2008; 27:589.
          </a>
         </li>
         <li class="breakAll">
          GeneReviews: Treacher Collins Syndrome. http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/books/NBK1532/ (Accessed on April 27, 2012).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schlump JU, Stein A, Hehr U, et al. Treacher Collins syndrome: clinical implications for the paediatrician--a new mutation in a severely affected newborn and comparison with three further patients with the same mutation, and review of the literature. Eur J Pediatr 2012; 171:1611.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Valdez BC, Henning D, So RB, et al. The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor. Proc Natl Acad Sci U S A 2004; 101:10709.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dixon J, Jones NC, Sandell LL, et al. Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities. Proc Natl Acad Sci U S A 2006; 103:13403.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jones NC, Farlie PG, Minichiello J, Newgreen DF. Detection of an appropriate kinase activity in branchial arches I and II that coincides with peak expression of the Treacher Collins syndrome gene product, treacle. Hum Mol Genet 1999; 8:2239.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dauwerse JG, Dixon J, Seland S, et al. Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome. Nat Genet 2011; 43:20.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Trainor PA. Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention. Am J Med Genet A 2010; 152A:2984.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Su PH, Chen JY, Chen SJ, Yu JS. Treacher Collins syndrome with a de Novo 5-bp deletion in the TCOF1 gene. J Formos Med Assoc 2006; 105:518.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tessier P. Anatomical classification facial, cranio-facial and latero-facial clefts. J Maxillofac Surg 1976; 4:69.
          </a>
         </li>
         <li class="breakAll">
          GeneReviews: Treacher Collins syndrome. http://www.ncbi.nlm.nih.gov/books/NBK1532/ (Accessed on June 24, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kobus K, Wójcicki P. Surgical treatment of Treacher Collins syndrome. Ann Plast Surg 2006; 56:549.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thompson JT, Anderson PJ, David DJ. Treacher Collins syndrome: protocol management from birth to maturity. J Craniofac Surg 2009; 20:2028.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Genecov DG, Barceló CR, Steinberg D, et al. Clinical experience with the application of distraction osteogenesis for airway obstruction. J Craniofac Surg 2009; 20 Suppl 2:1817.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tessier P. Autogenous bone grafts taken from the calvarium for facial and cranial applications. Clin Plast Surg 1982; 9:531.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy JG, Zide BM. The spectrum of calvarial bone grafting: introduction of the vascularized calvarial bone flap. Plast Reconstr Surg 1984; 74:10.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCarthy JG, Cutting CB, Shaw WW. Vascularized calvarial flaps. Clin Plast Surg 1987; 14:37.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saadeh PB, Chang CC, Warren SM, et al. Microsurgical correction of facial contour deformities in patients with craniofacial malformations: a 15-year experience. Plast Reconstr Surg 2008; 121:368e.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arndt EM, Travis F, Lefebvre A, Munro IR. Psychosocial adjustment of 20 patients with Treacher Collins syndrome before and after reconstructive surgery. Br J Plast Surg 1987; 40:605.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shprintzen RJ. The implications of the diagnosis of Robin sequence. Cleft Palate Craniofac J 1992; 29:205.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evans KN, Sie KC, Hopper RA, et al. Robin sequence: from diagnosis to development of an effective management plan. Pediatrics 2011; 127:936.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           van den Elzen AP, Semmekrot BA, Bongers EM, et al. Diagnosis and treatment of the Pierre Robin sequence: results of a retrospective clinical study and review of the literature. Eur J Pediatr 2001; 160:47.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Benko S, Fantes JA, Amiel J, et al. Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence. Nat Genet 2009; 41:359.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bütow KW, Hoogendijk CF, Zwahlen RA. Pierre Robin sequence: appearances and 25 years of experience with an innovative treatment protocol. J Pediatr Surg 2009; 44:2112.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poets CF, Bacher M. Treatment of upper airway obstruction and feeding problems in Robin-like phenotype. J Pediatr 2011; 159:887.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leboulanger N, Picard A, Soupre V, et al. Physiologic and clinical benefits of noninvasive ventilation in infants with Pierre Robin sequence. Pediatrics 2010; 126:e1056.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wagener S, Rayatt SS, Tatman AJ, et al. Management of infants with Pierre Robin sequence. Cleft Palate Craniofac J 2003; 40:180.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Parhizkar N, Saltzman B, Grote K, et al. Nasopharyngeal airway for management of airway obstruction in infants with micrognathia. Cleft Palate Craniofac J 2011; 48:478.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abel F, Bajaj Y, Wyatt M, Wallis C. The successful use of the nasopharyngeal airway in Pierre Robin sequence: an 11-year experience. Arch Dis Child 2012; 97:331.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denny AD, Talisman R, Hanson PR, Recinos RF. Mandibular distraction osteogenesis in very young patients to correct airway obstruction. Plast Reconstr Surg 2001; 108:302.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denny A, Kalantarian B. Mandibular distraction in neonates: a strategy to avoid tracheostomy. Plast Reconstr Surg 2002; 109:896.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denny AD. Distraction osteogenesis in Pierre Robin neonates with airway obstruction. Clin Plast Surg 2004; 31:221.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Denny AD, Amm CA, Schaefer RB. Outcomes of tongue-lip adhesion for neonatal respiratory distress caused by Pierre Robin sequence. J Craniofac Surg 2004; 15:819.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cozzi F, Totonelli G, Frediani S, et al. The effect of glossopexy on weight velocity in infants with Pierre Robin syndrome. J Pediatr Surg 2008; 43:296.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           NAGER G. [Not Available]. Pract Otorhinolaryngol (Basel) 1948; 10:184.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hunt JA, Hobar PC. Common craniofacial anomalies: the facial dysostoses. Plast Reconstr Surg 2002; 110:1714.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mackeprang M, Hay S. Cleft lip and palate mortality study. Cleft Palate J 1972; 9:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bernier FP, Caluseriu O, Ng S, et al. Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome. Am J Hum Genet 2012; 90:925.
          </a>
         </li>
         <li class="breakAll">
          Jones KL. Nager syndrome (Nager acrofacial dysostosis syndrome). In: Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006. p.288.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herrmann BW, Karzon R, Molter DW. Otologic and audiologic features of Nager acrofacial dysostosis. Int J Pediatr Otorhinolaryngol 2005; 69:1053.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ho AS, Aleshi P, Cohen SE, et al. Airway management in Nager Syndrome. Int J Pediatr Otorhinolaryngol 2008; 72:1885.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gürsoy S, Hukki J, Hurmerinta K. Five year follow-up of mandibular distraction osteogenesis on the dentofacial structures of syndromic children. Orthod Craniofac Res 2008; 11:57.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nedev PK. The Binder syndrome: review of the literature and case report. Int J Pediatr Otorhinolaryngol 2008; 72:1573.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sheffield LJ, Halliday JL, Jensen F. Maxillonasal dysplasia (Binder's syndrome) and chondrodysplasia punctata. J Med Genet 1991; 28:503.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Horswell BB, Holmes AD, Barnett JS, Levant BA. Maxillonasal dysplasia (Binder's syndrome): a critical review and case study. J Oral Maxillofac Surg 1987; 45:114.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Posnick JC. Surgical management of binder syndrome: lessons learned. Aesthetic Plast Surg 2010; 34:731.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmes AD, Lee SJ, Greensmith A, et al. Nasal reconstruction for maxillonasal dysplasia. J Craniofac Surg 2010; 21:543.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kruk-Jeromin J, Antoszewski B. [Binder's syndrome--symptoms and treatment]. Otolaryngol Pol 2006; 60:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gewalli F, Berlanga F, Monasterio FO, Holmström H. Nasomaxillary reconstruction in Binder syndrome: bone versus cartilage grafts. A long-term intercenter comparison between Sweden and Mexico. J Craniofac Surg 2008; 19:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Holmström H, Gewalli F. Long-term behavior of three different grafts in nasomaxillary reconstruction of binder syndrome: an analysis by digitalized measurements. Plast Reconstr Surg 2008; 122:1524.
          </a>
         </li>
         <li class="breakAll">
          GeneReviews: 22q11.2 Deletion Syndrome. http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/books/NBK1523/?log$=disease_name (Accessed on June 27, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           McDonald-McGinn DM, Sullivan KE. Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Medicine (Baltimore) 2011; 90:1.
          </a>
         </li>
         <li class="breakAll">
          Jones KL. Deletion 22q11.2 syndrome (Velo-cardio-facial syndrome, DiGeorge syndrome, Shprintzen syndrome). In: Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006. p.298.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gothelf D, Frisch A, Michaelovsky E, et al. Velo-Cardio-Facial Syndrome. J Ment Health Res Intellect Disabil 2009; 2:149.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jolin EM, Weller RA, Weller EB. Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome). Curr Psychiatry Rep 2009; 11:99.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eliez S, Blasey CM, Schmitt EJ, et al. Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia? Am J Psychiatry 2001; 158:447.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kates WR, Burnette CP, Bessette BA, et al. Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2). J Child Neurol 2004; 19:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Swanson EW, Sullivan SR, Ridgway EB, et al. Speech outcomes following pharyngeal flap in patients with velocardiofacial syndrome. Plast Reconstr Surg 2011; 127:2045.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rottgers SA, Ford M, Cray J, et al. An algorithm for application of furlow palatoplasty to the treatment of velocardiofacial syndrome-associated velopharyngeal insufficiency. Ann Plast Surg 2011; 66:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Arneja JS, Hettinger P, Gosain AK. Through-and-through dissection of the soft palate for high pharyngeal flap inset: a new technique for the treatment of velopharyngeal incompetence in velocardiofacial syndrome. Plast Reconstr Surg 2008; 122:845.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Finkelstein Y, Zohar Y, Nachmani A, et al. The otolaryngologist and the patient with velocardiofacial syndrome. Arch Otolaryngol Head Neck Surg 1993; 119:563.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cervelli V, Bottini DJ, Grimaldi M, et al. The Stickler syndrome. A genetic disease with clinical implications for the plastic surgeon. J Plast Reconstr Aesthet Surg 2008; 61:987.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Richards AJ, McNinch A, Martin H, et al. Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1. Hum Mutat 2010; 31:E1461.
          </a>
         </li>
         <li class="breakAll">
          GeneReviews: Stickler Syndrome. http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/books/NBK1302/ (Accessed on June 27, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Snead MP, Yates JR. Clinical and Molecular genetics of Stickler syndrome. J Med Genet 1999; 36:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Annunen S, Körkkö J, Czarny M, et al. Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes. Am J Hum Genet 1999; 65:974.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sirko-Osadsa DA, Murray MA, Scott JA, et al. Stickler syndrome without eye involvement is caused by mutations in COL11A2, the gene encoding the alpha2(XI) chain of type XI collagen. J Pediatr 1998; 132:368.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker S, Booth C, Fillman C, et al. A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome. Am J Med Genet A 2011; 155A:1668.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nikopoulos K, Schrauwen I, Simon M, et al. Autosomal recessive Stickler syndrome in two families is caused by mutations in the COL9A1 gene. Invest Ophthalmol Vis Sci 2011; 52:4774.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vilaplana F, Muiños SJ, Nadal J, et al. Stickler syndrome. Epidemiology of retinal detachment. Arch Soc Esp Oftalmol 2015; 90:264.
          </a>
         </li>
         <li class="breakAll">
          Jones KL. Marshall syndrome. In: Smith's recognizable patterns of human malformation, 6th ed, Elsevier Saunders, Philadelphia 2006. p.282.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shanske AL, Bogdanow A, Shprintzen RJ, Marion RW. The Marshall syndrome: report of a new family and review of the literature. Am J Med Genet 1997; 70:52.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koillinen H, Wong FK, Rautio J, et al. Mapping of the second locus for the Van der Woude syndrome to chromosome 1p34. Eur J Hum Genet 2001; 9:747.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Houdayer C, Soupre V, Rosenberg-Bourgin M, et al. Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease trait. Ann Genet 1999; 42:69.
          </a>
         </li>
         <li class="breakAll">
          GeneReviews: IRF6-related disorders. http://www.ncbi.nlm.nih.gov.ezp-prod1.hul.harvard.edu/pubmed/20301581 (Accessed on June 27, 2011).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rorick NK, Kinoshita A, Weirather JL, et al. Genomic strategy identifies a missense mutation in WD-repeat domain 65 (WDR65) in an individual with Van der Woude syndrome. Am J Med Genet A 2011; 155A:1314.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2926 Version 28.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33723764" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Craniofacial Development: Neural Crest in Molecular Embryology.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4689671" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : On hemifacial microsomia. The first and second branchial arch syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4689671" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : On hemifacial microsomia. The first and second branchial arch syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17506093" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Oculo-auriculo-vertebral spectrum: associated anomalies, functional deficits and possible developmental risk factors.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19203801" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Treatment of otological features of the oculoauriculovertebral dysplasia (Goldenhar syndrome).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21467824" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Craniofacial and dental characteristics of Goldenhar syndrome: a report of two cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11810276" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Hemifacial microsomia: progress in understanding the genetic basis of a complex malformation syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18792983" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Further evidence for a relationship between the 5p15 chromosome region and the oculoauriculovertebral anomaly.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19305190" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Oculoauriculovertebral spectrum: report of nine familial cases with evidence of autosomal dominant inheritance and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17159507" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : A family with autosomal dominant oculo-auriculo-vertebral spectrum.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4631568" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The pathogenesis of the first and second branchial arch syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1848447" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The O.M.E.N.S. classification of hemifacial microsomia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18090735" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Hemifacial microsomia: clinical features and pictographic representations of the OMENS classification system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Not all dwarfed mandibles are alike
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10447900" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Hemifacial microsomia: anatomical prediction of difficult intubation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9251608" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Occlusal cant in the frontal plane as a reflection of facial asymmetry.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7578205" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : OMENS-Plus: analysis of craniofacial and extracraniofacial anomalies in hemifacial microsomia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21200224" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : A phenotypic assessment tool for craniofacial microsomia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4579163" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : The corrective treatment of the skeletal asymmetry in hemifacial microsomia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1727238" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Lengthening the human mandible by gradual distraction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10190432" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Mandibular growth after distraction in patients under 48 months of age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10724246" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Distraction osteogenesis: a new surgical technique for use with the multiplanar mandibular distractor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16980861" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Long-term stability and growth following unilateral mandibular distraction in growing children with craniofacial microsomia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21454084" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Comparison of mandibular vertical growth in hemifacial microsomia patients treated with early distraction or not treated: follow up till the completion of growth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18442918" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Does functional appliance treatment truly improve stability of mandibular vertical distraction osteogenesis in hemifacial microsomia?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19816351" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : External ear reconstruction in hemifacial microsomia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18617112" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Longitudinal growth changes in untreated subjects with Class II Division 1 malocclusion.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9246513" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Craniofacial microsomia. A primary or secondary surgical treatment program.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7652053" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Microvascular free-flap correction of severe hemifacial atrophy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17552945" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Treacher Collins syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8563749" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Positional cloning of a gene involved in the pathogenesis of Treacher Collins syndrome. The Treacher Collins Syndrome Collaborative Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9736782" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Mutations in the Treacher Collins syndrome gene lead to mislocalization of the nucleolar protein treacle.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18771418" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Regulation of the mouse Treacher Collins syndrome homolog (Tcof1) promoter through differential repression of constitutive expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18771418" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Regulation of the mouse Treacher Collins syndrome homolog (Tcof1) promoter through differential repression of constitutive expression.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22729243" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Treacher Collins syndrome: clinical implications for the paediatrician--a new mutation in a severely affected newborn and comparison with three further patients with the same mutation, and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15249688" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : The Treacher Collins syndrome (TCOF1) gene product is involved in ribosomal DNA gene transcription by interacting with upstream binding factor.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16938878" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Tcof1/Treacle is required for neural crest cell formation and proliferation deficiencies that cause craniofacial abnormalities.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10545604" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : Detection of an appropriate kinase activity in branchial arches I and II that coincides with peak expression of the Treacher Collins syndrome gene product, treacle.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21131976" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Mutations in genes encoding subunits of RNA polymerases I and III cause Treacher Collins syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20734335" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Craniofacial birth defects: The role of neural crest cells in the etiology and pathogenesis of Treacher Collins syndrome and the potential for prevention.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16801042" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : Treacher Collins syndrome with a de Novo 5-bp deletion in the TCOF1 gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/820824" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Anatomical classification facial, cranio-facial and latero-facial clefts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/820824" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Anatomical classification facial, cranio-facial and latero-facial clefts.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16641634" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Surgical treatment of Treacher Collins syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19881372" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Treacher Collins syndrome: protocol management from birth to maturity.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19816357" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Clinical experience with the application of distraction osteogenesis for airway obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6756759" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Autogenous bone grafts taken from the calvarium for facial and cranial applications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/6739582" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The spectrum of calvarial bone grafting: introduction of the vascularized calvarial bone flap.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3816036" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Vascularized calvarial flaps.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18520863" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Microsurgical correction of facial contour deformities in patients with craniofacial malformations: a 15-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3690093" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Psychosocial adjustment of 20 patients with Treacher Collins syndrome before and after reconstructive surgery.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1591252" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : The implications of the diagnosis of Robin sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21464188" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Robin sequence: from diagnosis to development of an effective management plan.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11195018" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Diagnosis and treatment of the Pierre Robin sequence: results of a retrospective clinical study and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19234473" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Highly conserved non-coding elements on either side of SOX9 associated with Pierre Robin sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19944218" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Pierre Robin sequence: appearances and 25 years of experience with an innovative treatment protocol.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21885059" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Treatment of upper airway obstruction and feeding problems in Robin-like phenotype.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20956415" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : Physiologic and clinical benefits of noninvasive ventilation in infants with Pierre Robin sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12605525" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Management of infants with Pierre Robin sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20815716" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Nasopharyngeal airway for management of airway obstruction in infants with micrognathia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22331679" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : The successful use of the nasopharyngeal airway in Pierre Robin sequence: an 11-year experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11496167" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : Mandibular distraction osteogenesis in very young patients to correct airway obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11884804" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : Mandibular distraction in neonates: a strategy to avoid tracheostomy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15145664" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Distraction osteogenesis in Pierre Robin neonates with airway obstruction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15346025" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Outcomes of tongue-lip adhesion for neonatal respiratory distress caused by Pierre Robin sequence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18280277" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : The effect of glossopexy on weight velocity in infants with Pierre Robin syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18908762" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : [Not Available].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12447054" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Common craniofacial anomalies: the facial dysostoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4500296" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Cleft lip and palate mortality study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22541558" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22541558" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Haploinsufficiency of SF3B4, a component of the pre-mRNA spliceosomal complex, causes Nager syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16005346" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Otologic and audiologic features of Nager acrofacial dysostosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18947886" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Airway management in Nager Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18199081" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Five year follow-up of mandibular distraction osteogenesis on the dentofacial structures of syndromic children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18691769" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : The Binder syndrome: review of the literature and case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1842210" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Maxillonasal dysplasia (Binder's syndrome) and chondrodysplasia punctata.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3468213" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : Maxillonasal dysplasia (Binder's syndrome): a critical review and case study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20972568" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Surgical management of binder syndrome: lessons learned.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20216441" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Nasal reconstruction for maxillonasal dysplasia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16903341" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : [Binder's syndrome--symptoms and treatment].
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18812845" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Nasomaxillary reconstruction in Binder syndrome: bone versus cartilage grafts. A long-term intercenter comparison between Sweden and Mexico.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18971737" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Long-term behavior of three different grafts in nasomaxillary reconstruction of binder syndrome: an analysis by digitalized measurements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18971737" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Long-term behavior of three different grafts in nasomaxillary reconstruction of binder syndrome: an analysis by digitalized measurements.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21200182" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21200182" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : Chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20111667" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Velo-Cardio-Facial Syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19302762" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Psychosis in children with velocardiofacial syndrome (22q11.2 deletion syndrome).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11229987" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Velocardiofacial syndrome: are structural changes in the temporal and mesial temporal regions related to schizophrenia?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15224707" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Frontal and caudate alterations in velocardiofacial syndrome (deletion at chromosome 22q11.2).
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21532431" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Speech outcomes following pharyngeal flap in patients with velocardiofacial syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21451369" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : An algorithm for application of furlow palatoplasty to the treatment of velocardiofacial syndrome-associated velopharyngeal insufficiency.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18766049" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Through-and-through dissection of the soft palate for high pharyngeal flap inset: a new technique for the treatment of velopharyngeal incompetence in velocardiofacial syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8484947" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : The otolaryngologist and the patient with velocardiofacial syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18458010" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : The Stickler syndrome. A genetic disease with clinical implications for the plastic surgeon.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20513134" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20513134" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Stickler syndrome and the vitreous phenotype: mutations in COL2A1 and COL11A1.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10353778" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Clinical and Molecular genetics of Stickler syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10486316" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : Splicing mutations of 54-bp exons in the COL11A1 gene cause Marshall syndrome, but other mutations cause overlapping Marshall/Stickler phenotypes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9506662" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Stickler syndrome without eye involvement is caused by mutations in COL11A2, the gene encoding the alpha2(XI) chain of type XI collagen.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21671392" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : A loss of function mutation in the COL9A2 gene causes autosomal recessive Stickler syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21421862" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Autosomal recessive Stickler syndrome in two families is caused by mutations in the COL9A1 gene.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25817961" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Stickler syndrome. Epidemiology of retinal detachment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25817961" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Stickler syndrome. Epidemiology of retinal detachment.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9129742" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : The Marshall syndrome: report of a new family and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11781685" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Mapping of the second locus for the Van der Woude syndrome to chromosome 1p34.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10434119" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease trait.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10434119" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Linkage analysis of 5 novel van der Woude syndrome kindreds to 1q32-q41 markers further supports locus homogeneity of the disease trait.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21574244" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Genomic strategy identifies a missense mutation in WD-repeat domain 65 (WDR65) in an individual with Van der Woude syndrome.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
